Pacritinib Effectively Reduces Symptoms in Patients With Myelofibrosis, Monocytosis | Blood Cancers Today
A retrospective analysis covered two phase III trials of the JAK2 inhibitor in patients with and without monocytosis.
A retrospective analysis covered two phase III trials of the JAK2 inhibitor in patients with and without monocytosis.
Scientific Reports – Eight weeks of aerobic exercise, but not four, improves insulin sensitivity and cardiovascular performance in young women
Dementia affects millions of people and millions more of their caregivers — staggering numbers that are projected to triple by 2050. In response, the World Health Organization…
The superfood provides anti-inflammatory plant compounds as well as fiber, vitamins and minerals.
WASHINGTON, DC, January 14, 2025 — The Food & Drug Administration (FDA) today announced a proposed rule for a front-of-pack nutrition labeling system for foods…
UPI delivers the latest headlines from around the world: Top News, Entertainment, Health, Business, Science and Sports News – United Press International
Older and frail adult patients with multiple myeloma treated with idecabtagene vicleucel (ide-cel), a B-cell maturation agent targeting chimeric antigen receptor (CAR)-T product, have comparable…
The findings underscore the message that “it’s never too early to think about your heart health.”
Treatment of MF with momelotinib as a first- or second-line therapy outside of a clinical trial yielded significant improvements in anemia and survival rates.
The following is a summary of the study titled “Thyroid Function Status in Patients with Hypothyroidism on Thyroxine Replacement and Associated Factors: A Retrospective Cohort…
Veganuary isn’t just for millennials and younger people!